HDAC4-Myogenin Axis As an Important Marker of HD-Related Skeletal Muscle Atrophy
Open Access
- 6 March 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 11 (3) , e1005021
Abstract
Skeletal muscle remodelling and contractile dysfunction occur through both acute and chronic disease processes. These include the accumulation of insoluble aggregates of misfolded amyloid proteins that is a pathological feature of Huntington’s disease (HD). While HD has been described primarily as a neurological disease, HD patients’ exhibit pronounced skeletal muscle atrophy. Given that huntingtin is a ubiquitously expressed protein, skeletal muscle fibres may be at risk of a cell autonomous HD-related dysfunction. However the mechanism leading to skeletal muscle abnormalities in the clinical and pre-clinical HD settings remains unknown. To unravel this mechanism, we employed the R6/2 transgenic and HdhQ150 knock-in mouse models of HD. We found that symptomatic animals developed a progressive impairment of the contractile characteristics of the hind limb muscles tibialis anterior (TA) and extensor digitorum longus (EDL), accompanied by a significant loss of motor units in the EDL. In symptomatic animals, these pronounced functional changes were accompanied by an aberrant deregulation of contractile protein transcripts and their up-stream transcriptional regulators. In addition, HD mouse models develop a significant reduction in muscle force, possibly as a result of a deterioration in energy metabolism and decreased oxidation that is accompanied by the re-expression of the HDAC4-DACH2-myogenin axis. These results show that muscle dysfunction is a key pathological feature of HD. Huntington’s disease (HD) is a neurodegenerative disorder in which the mutation results in an extra-long tract of glutamines that causes the huntingtin protein to aggregate. It is characterized by neurological symptoms and brain pathology, which is associated with nuclear and cytoplasmic protein aggregates and with transcriptional deregulation. Despite the fact that HD has been recognized principally as a neurological disease, there are multiple studies indicating that peripheral pathologies including cardiac dysfunction and skeletal muscle atrophy, contribute to the overall progression of HD. To unravel the cause of the skeletal muscle dysfunction, we applied a wide range of molecular and physiological methods to the analysis of two well established genetic mouse models of this disease. We found that symptomatic animals developed muscle dysfunction characterised by a change in the contractile characteristics of fast twitch muscles and a decrease in twitch and tetanic force of hindlimb muscles. In addition, there is a significant decrease in the number of motor units innervating the EDL muscle, and this motor unit loss progresses during the course of the disease. These changes were accompanied by the re-expression of contractile transcripts and markers of muscle denervation such as the HDAC4-Dach2-myogenin axis, as well as the apparent deterioration in energy metabolism and decreased oxidation. Therefore, we conclude, that the HD-related skeletal muscle atrophy is accompanied by progressive loss of functional motor units.Keywords
This publication has 69 references indexed in Scilit:
- Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunctionProceedings of the National Academy of Sciences, 2013
- Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington diseaseProceedings of the National Academy of Sciences of the United States of America, 2013
- Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashionActa Neuropathologica, 2012
- Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's diseaseHuman Molecular Genetics, 2011
- Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's diseaseMovement Disorders, 2010
- MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in MiceScience, 2009
- Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's diseaseHuman Molecular Genetics, 2009
- Role of mitochondrial dysfunction in the pathogenesis of Huntington's diseaseBrain Research Bulletin, 2009
- Overexpression of TEAD-1 in Transgenic Mouse Striated Muscles Produces a Slower Skeletal Muscle Contractile PhenotypeJournal of Biological Chemistry, 2008
- The deacetylase HDAC4 controls myocyte enhancing factor‐2‐dependent structural gene expression in response to neural activityThe FASEB Journal, 2008